Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database

• Main Authors: Dan Li (Author), Yuan Zhang (Author), Jia Qi Ni (Author), Juan Zhu (Author), Wen Ting Lu (Author), Ya Lin Chen (Author), Lei Cheng (Author), Yu Qi Wang (Author), Qian Jiang Li (Author), Jie Wang (Author), Yan Bing Lu (Author), Jia Chen (Author), Li Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Bendamustine was approved for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Despite its therapeutic benefits, the long-term safety of bendamustine in a large population remains inadequately understood. This study evaluates the adverse events (AEs) associa...